Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk — NAMU

Hydrocephalus in Infants Clinical Trial

Official title:
Proteomics of Cerebrospinal Fluid of Preterm Infants With Posthemorrhagic Hydrocephalus With Focus on Intranasal Breast Milk.

Status Recruiting

Clinical Trial Summary

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.

Clinical Trial Description

Since the nasal route might be highly effective for neurotrophins and other growth factors the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating effects of intranasal breast milk application on the cerebrospinal fluid proteom. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04229693
Study type	Observational
Source	University Hospital of Cologne
Contact	Titus Keller, MD
Phone	0049 221 4449
Email	titus.keller@uk-koeln.de
Status	Recruiting
Phase
Start date	February 7, 2020
Completion date	August 2021

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05762848` - Clinical Application and Functionality for an Application for Measurement of Head Circumference.
	Not yet recruiting	`NCT06310213` - Non-Invasive Pressure Monitor for Neonates & Infants at Risk of Developing Hydrocephalus	N/A